Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/24/2015 07/27/2015 07/28/2015 07/29/2015 07/30/2015 Date
0.4055(c) 0.4001(c) 0.44(c) 0.44(c) 0.4311 Last
1 889 344 2 020 176 4 517 392 2 063 422 860 219 Volume
-7.84% -1.33% +9.97% 0.00% -2.02% Change
More quotes
Financials ($)
Sales 2015 12,9 M
EBIT 2015 -24,1 M
Net income 2015 -36,7 M
Debt 2015 -
Yield 2015 -
Sales 2016 28,5 M
EBIT 2016 -13,3 M
Net income 2016 -15,8 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 5,17x
Capi. / Sales 2016 2,33x
Capitalization 66,4 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
08:03a CYTORI THERAPEUTICS : Japanese Approval Trial for Stress Urinary Incontinence Us..
04:06a CYTORI THERAPEUTICS : Schedules 2nd Quarter Financial Results Update
07/29 CYTORI THERAPEUTICS : Appoints VP of Business Development and General Counsel
07/28 CYTORI THERAPEUTICS : Licensee Kerastem Receives Conditional Approval from FDA f..
07/27 CYTORI THERAPEUTICS : Second Quarter Financial Results Update
07/07 CYTORI THERAPEUTICS : Change in Directors or Principal Officers (form 8-K)
06/24 CYTORI THERAPEUTICS : Completes Enrollment in US Phase IIb Osteoarthritis Trial
06/18 CYTORI THERAPEUTICS : Finalizes Enrollment in US Phase IIb Osteoarthritis Trial
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02:10p BAXALTA : Baxter's spinoff -- raises expectations for second half (BRIEF)
10:06a MEDTRONIC : Supports First Retreat & Refresh Stroke Camp for Stroke Survivors an..
09:51a SMITH & NEPHEW : Keeps Expectations As First-Half Profit Rises (UPDATE)
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
05/15 Healthcare ratings roundup - new coverage (part 2)
05/12 Cytori Therapeutics reports Q1 results
05/12 Cytori Therapeutics (CYTX) Marc H. Hedrick on Q1 2015 Results - Earnings Call..
05/10 Notable earnings after Monday?s close
05/08 NEXT WEEK IN BIOTECH : ASCO Abstracts, Pernix PDUFA, Celladon Earnings


Comments 
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Technical analysis trends CYTORI THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions